Outlook Therapeutics (OTLK) Share-based Compensation (2015 - 2026)
Outlook Therapeutics (OTLK) recorded Share-based Compensation of $791,670 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 52.9% from $1.68 million a year earlier but up 4.5% from the prior quarter.
Outlook Therapeutics (OTLK) Share-based Compensation (2015 - 2026) Analysis & Trends
On a TTM basis, Outlook Therapeutics' Share-based Compensation came in at $4.25 million as of Jun 30, 2026, down 49.9% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $8.9 million, up 65.2% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 25.9% (FY2020 to FY2025).
- Across earlier fiscal years, Share-based Compensation came in at $5.39 million in FY2024 (-2.9%), $5.55 million in FY2023 (-28.1%), $7.71 million in FY2022 (+57.8%) and $4.89 million in FY2021 (+74.1%).
- Quarterly Share-based Compensation has ranged from $757,484 in fiscal Q2 2026 to $3.76 million in fiscal Q2 2022 over the past five years.
- On a year-over-year basis, Share-based Compensation has declined for three consecutive quarters, with growth averaging 10.8% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 233.1% in fiscal Q2 2022, against a decline of 76.0% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $757,484 (Q2 2026), $881,150 (Q1 2026) and $1.82 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Outlook Therapeutics | 84.78 Mn | 49.03 Mn | -8,265.00 | 791,670.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 791,670.00 |
| Mar 31, 2026 | 757,484.00 |
| Dec 31, 2025 | 881,150.00 |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 3.67 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.39 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 1.40 Mn |
Outlook Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();